Latest articles

[This article is an outside contribution by Dr Patricia Lepage (INRA), co-author of the paper. For further references about the author, see the short bio hereunder]   Research jointly conducted by investigators at Institut Gustave Roussy, Inserm, Institut Pasteur and INRA (National Agronomic Research Institute) in France has led to a rather surprising discovery on the manner in which cancer chemotherapy treatments act more effectively with the help of the intestinal flora (also known as the intestinal microbiota). Researchers have shown that the efficacy of one of the molecules most often used in chemotherapy relies to an extent on its capacity to mobilise certain bacteria from the intestinal microbiota toward…

The gut mobile metagenome comprises mobile genetic element (MGE) like bacterial viruses, known as bacteriophages. Although few studies showed that there is high interpersonal variation, little is known about how the gut microbiota react under…

(Berlin, October 16, 2013) Clinicians with gastrointestinal (GI) patients often wish – and are asked by their patients – to recommend specific probiotics. However, a clear and accessible evidence-based reference guide on the role and effectiveness of specific probiotics and their clinical use for managing particular lower gastrointestinal problems has been lacking so far. Now a new reference guide, which was supported and facilitated by the European Society for Primary Care Gastroenterology (ESPCG), with a focus on the requirements of primary care physicians, provides the first practical consensus on the role of specific probiotics in the management of lower GI symptoms in adults in clinical practice. The guide will also…

On Monday 30th September, 2013, UC Davis hosted the 2013 CHAMMP (Center of Health for Advancing Microbiome and Mucosal Protection) Symposium on "Advancing microbiome and mucosal protection in chronic inflammatory disease and development". The event welcomed 8 presentations, with a keynote by Dr Jeffrey Gordon, and ended with a discussion panel.   You can check the program on this page.   Dr Jonathan Eisen, co-moderator of the discussion panel, also put together a Storify gathering tweets from the event :     [<a href="//storify.com/phylogenomics/ucdavis-chammp" target="_blank">View the story "#UCDavis #CHAMMP symposium on microbiomes" on Storify</a>]

Twitter

Twitter


Follow @GMFHx
Upcoming events
See all events
News archive
Access from here to the chronological archive of news of this site
Access archive
Research & Practice
Latest articles

[This article is an outside contribution by Dr Patricia Lepage (INRA), co-author of the paper. For further references about the author, see the short bio hereunder]   Research jointly conducted by investigators at Institut Gustave Roussy, Inserm, Institut Pasteur and INRA (National Agronomic Research Institute) in France has led to a rather surprising discovery on the manner in which cancer chemotherapy treatments act more effectively with the help of the intestinal flora (also known as the intestinal microbiota). Researchers have shown that the efficacy of one of the molecules most often used in chemotherapy relies to an extent on its capacity to mobilise certain bacteria from the intestinal microbiota toward…

The gut mobile metagenome comprises mobile genetic element (MGE) like bacterial viruses, known as bacteriophages. Although few studies showed that there is high interpersonal variation, little is known about how the gut microbiota react under…

(Berlin, October 16, 2013) Clinicians with gastrointestinal (GI) patients often wish – and are asked by their patients – to recommend specific probiotics. However, a clear and accessible evidence-based reference guide on the role and effectiveness of specific probiotics and their clinical use for managing particular lower gastrointestinal problems has been lacking so far. Now a new reference guide, which was supported and facilitated by the European Society for Primary Care Gastroenterology (ESPCG), with a focus on the requirements of primary care physicians, provides the first practical consensus on the role of specific probiotics in the management of lower GI symptoms in adults in clinical practice. The guide will also…

On Monday 30th September, 2013, UC Davis hosted the 2013 CHAMMP (Center of Health for Advancing Microbiome and Mucosal Protection) Symposium on "Advancing microbiome and mucosal protection in chronic inflammatory disease and development". The event welcomed 8 presentations, with a keynote by Dr Jeffrey Gordon, and ended with a discussion panel.   You can check the program on this page.   Dr Jonathan Eisen, co-moderator of the discussion panel, also put together a Storify gathering tweets from the event :     [<a href="//storify.com/phylogenomics/ucdavis-chammp" target="_blank">View the story "#UCDavis #CHAMMP symposium on microbiomes" on Storify</a>]

Meet our board of experts